by David Kent | Apr 15, 2014
> In February this year, the biggest stem cell trial for heart attack patients was begun and will involve over 3000 patients from 11 different countries in Europe. The BAMI trial (the effect of intracoronary reinfusion of Bone marrow-derived mononuclear cells on...
by Alessandra Pasut | Apr 2, 2014
Editor’s note: Some of the links included are Italian language sources The case involving Stamina Foundation and the legitimacy of its stem cell treatments has been one of the most discussed and controversial issues in the international stem cell policy scene....
by Mark Curtis | Feb 4, 2014
. Welcome to your Update from the Clinic for the month of January! We start the year off with the German health authority approving Pluristem’s next generation GMP cell manufacturing facility. Neuralstem successfully, and safely, transplants NSI-556 cells directly...
by Lisa Willemse | Jan 31, 2014
> By now, most readers will be familiar with this week’s announcement of a remarkable new discovery that mouse cells were made pluripotent using a relatively simple and quick acid bath technique. For those who aren’t, there’s reams of coverage,...
by Paul Krzyzanowski | Jan 9, 2014
> If your morning cup of coffee wasn’t enough to wake you up today, researchers from the New York Stem Cell Foundation and Columbia University just reported being able to generate iPS cells from human brain tissue that’s been frozen for 11 years:...
by Mark Curtis | Jan 7, 2014
. Welcome to your Update from the Clinic for the month of December. Athersys and NeoStem both confirm completion of enrollment for phase 2 studies while bluebird bio announces the first patient transplanted in its phase 1/2 study of HGB-205 in patients with...
Comments